US FDA Center for Biologics Evaluation & Research Director Peter Marks hopes that the option for employees to work remotely from outside the Washington, D.C. area – on a permanent basis, even after the pandemic is over – will help offset what is expected to be increased rate of attrition after the strains of the COVID pandemic.
“One of the things in terms of our hiring priorities that’s been made a little bit easier by COVID-19 is that we have shattered the previous connection when people had to be in the DC-Maryland-Virginia general area so they could come to
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?